title: Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation.
abstract: BACKGROUND
  Kidney transplantation is the gold standard of therapy in patients with terminal renal insufficiency. Living donor transplantation is a well-established option in this field. Enlarging the donor's pool implicates the acceptance of an increased rate of comorbidities. Among them, coronary artery disease is a growing problem. An increasing number of patients, undergoing living donation, receive antiplatelet therapies due to coronary disease.
  
  
  METHODS
  Here we report about the perioperative treatment with a drug-eluting balloon in a patient with major cardiac risk factors who underwent kidney transplantation.
  
  
  CONCLUSIONS
  At the current time no recommendation can be given for the routine use of drug-eluting balloons.
authors.forename: Tobias
authors.initials: T
authors.lastname: Kammerer
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, University Hospital, JW Goethe-University, Theodor-Stern-Kai 7, 61590 Frankfurt, Germany. andres.beiras@kgu.de.
authors.forename: Andres
authors.initials: A
authors.lastname: Beiras-Fernandez
authors.forename: Markus
authors.initials: M
authors.lastname: Rehm
authors.forename: Manfred
authors.initials: M
authors.lastname: Stangl
authors.forename: Markus
authors.initials: M
authors.lastname: Guba
authors.forename: Christian
authors.initials: C
authors.lastname: Kupatt-Jeremias
authors.forename: Florian
authors.initials: F
authors.lastname: Weis
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D000925:Anticoagulants / Q000008:administration & dosage; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000628:therapy*; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D003328:Coronary Thrombosis / Q000209:etiology / Q000628:therapy; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000601:surgery*; D054855:Drug-Eluting Stents; D006801:Humans; D016030:Kidney Transplantation / Q000379:methods*; D019520:Living Donors; D008297:Male; D010348:Patient Care Team; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011474:Prosthesis Design; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors